2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
6
Pancreatic Neoplasms
4
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymus Neoplasms
1
Thymoma
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Pancreatitis
1
Pancreatic Diseases
1
Neoplasms, Germ Cell and Embryonal
1
Mesothelioma
1
Medulloblastoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Epilepsy
1
Ependymoma
1
Interventions
Temozolomide
159
Bevacizumab
69
Radiotherapy
68
Magnetic Resonance Spectroscopy
68
Irinotecan
31
Surgical Procedures, Operative
27
Radiation
24
Carboplatin
23
Specimen Handling
20
Carmustine
20
Blood Specimen Collection
20
Nivolumab
19
Aminolevulinic Acid
18
Biopsy
17
Lomustine
16
pembrolizumab
13
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
13
trametinib
12
fluorodopa F 18
12
X-Rays
12
Radiosurgery
12
Erlotinib Hydrochloride
12
Topotecan
11
Everolimus
11
Magnetic Resonance Imaging
10
IL13-PE38
10
dabrafenib
9
Etoposide
9
Drug Therapy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Histocompatibility Testing
×
Clear all
NCT06323408
2025-03-25
BZKF-AYA
University Hospital Regensburg
Not yet recruiting
72 enrolled